The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126678001 12667800 1 I 20160809 20160819 20160819 EXP IN-IMPAX LABORATORIES, INC-2016-IPXL-00893 IMPAX FLORIT-SUREDA M, CONDE-ESTEVEZ D, VIDAL J, MONTAGUT C.. HYPERSENSITIVITY REACTION CAUSED BY FOLINIC ACID ADMINISTRATION: A CASE REPORT AND LITERATURE REVIEW. JOURNAL OF CHEMOTHERAPY. 2016;1-6 16.00 YR M Y 0.00000 20160819 MD IN IN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126678001 12667800 1 PS LEUCOVORIN CALCIUM. LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) UNK Y 74544 TABLET
126678001 12667800 2 SS LEUCOVORIN CALCIUM. LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) (30 MG/M^2 AT HOUR 42 AND 15 MG/M^2 EACH AT HOURS 48 AND 54) Y 74544 TABLET
126678001 12667800 3 C METHOTREXATE. METHOTREXATE 1 Unknown (5 G/ M^2) 0
126678001 12667800 4 C METHOTREXATE. METHOTREXATE 1 Unknown HIGH DOSE 0
126678001 12667800 5 C ONDANSETRON ONDANSETRON 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126678001 12667800 1 Precursor T-lymphoblastic lymphoma/leukaemia stage III
126678001 12667800 3 Precursor T-lymphoblastic lymphoma/leukaemia stage III
126678001 12667800 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126678001 12667800 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126678001 12667800 Blood creatinine increased
126678001 12667800 Dizziness
126678001 12667800 Drug hypersensitivity
126678001 12667800 Hypotension
126678001 12667800 Rash erythematous
126678001 12667800 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found